Shelf-life extensions granted

alert shortage warning
Shortage of tenecteplase (Metalyse) injections has been advised after surging global demand Boehringer Ingelheim Australia has advised the TGA of "the likelihood of temporary supply interruptions" to tenecteplase (Metalyse) injection that is predicted to extend over the next 18 months. The shortage is due to manufacturing capacity constraints following increases in demand, said Boehringer Ingelheim.

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous World news wrapup: 14 July 2022
Next ‘The audacity:’ Pharmacist claps back at complainer